Skip to main content

ALKS- Alkermes Plc

Alkermes Plc (ALKS) has 14 insiders with recent SEC Form 4 filings, including 1 buy and 13 sells. ALKS is classified in the Pharmaceuticals industry within the Health Care sector.

Insider Ownership

RoleInsiderSharesValue30d
VP225.5K$11.24M-2,034
VP109.2K$5.44M-
VP69.4K$3.46M-9,000
Dir43.3K$2.16M-44,472
CFO36.7K$1.83M-

Activity

Buys and sells only

Transactions

10 filings · page 9
DateInsiderRoleTypeSharesPriceValueChg%SEC
Mar 26, 2020Pops Richard F57Director And CEO, Alkermes PlcSale+OE75,000$14.36$1,077,225.00-9.0%
Mar 24, 2020Landine Michael JSVP, Corp Dev., Alkermes, Inc.Sale+OE25,000$13.91$347,717.50-11.0%
Mar 19, 2020Pops Richard F57Director And CEO, Alkermes PlcSale+OE75,000$14.47$1,085,427.60-3.1%
Mar 17, 2020Landine Michael JSVP, Corp Dev., Alkermes, Inc.Sale+OE25,000$13.54$338,506.33-5.8%
Feb 24, 2020Wysenski NancyDirectorBuy6,940$19.65$136,371.00+161.3%
Nov 14, 2019Pops Richard F57Director And CEO, Alkermes PlcSale+OE100,000$19.50$1,950,000.00-12.2%
Nov 13, 2019Landine Michael JSVP, Corp Dev., Alkermes, Inc.Sale+OE20,000$19.70$394,056.00-9.8%
Nov 8, 2019Pops Richard F57Director And CEO, Alkermes PlcSale+OE100,000$19.78$1,978,444.86-6.5%
Nov 6, 2019Landine Michael JSVP, Corp Dev., Alkermes, Inc.Sale+OE20,000$19.76$395,116.00-9.8%
Sep 19, 2019Pops Richard F57Director And CEO, Alkermes PlcSale+OE100,000$21.54$2,153,550.00-12.2%